As filed with the Securities and Exchange Commission on May 14, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Accelerate Diagnostics, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware (State or other jurisdiction
of |
84-1072256 (I.R.S. Employer |
| 3950 South Country Club Road, Suite 470 Tucson, Arizona 85714 (Address of principal executive offices, including zip code) | |
Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan
(Full title of the plan)
Jack Phillips
President and Chief Executive Officer
3950 South Country Club Road, Suite 470
Tucson, Arizona 85714
(520) 365-3100
(Name, address and telephone number, including area code, of agent for service)
With a copy to:
Daniel M. Mahoney
Joshua Schneiderman
Snell & Wilmer L.L.P.
One East Washington Street
Suite 2700
Phoenix, Arizona 85004
(602) 382-6000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ¨ | Accelerated filer ¨ |
| Non-accelerated filer x | Smaller reporting company x |
| Emerging growth company ¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
EXPLANATORY NOTE
This registration statement is being filed solely for the registration of 4,000,000 additional shares of common stock, $0.001 par value per share, of Accelerate Diagnostics, Inc., a Delaware corporation (the “Company”), for issuance pursuant to the Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan (as amended, the “Plan”). Accordingly, pursuant to General Instruction E to Form S-8, the contents of the Company’s prior registration statements relating to the Plan (Nos. 333-265126 and 333-272792) are hereby incorporated by reference in this registration statement, except as revised in Part II of this registration statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents have been filed by the Company with the Securities and Exchange Commission (the “Commission”) and are hereby incorporated by reference in this registration statement:
| 1. | The Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Commission on March 29, 2024 (the “Form 10-K”). |
| 2. | The Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024, filed with the Commission on May 13, 2024. |
| 3. | The Company’s Current Reports on Form 8-K, filed with the Commission on January 25, 2024, March 5, 2024, April 30, 2024 and May 13, 2024. |
| 4. | The description of the Company’s common stock contained in its Registration Statement on Form 8-A (No. 001-31822), filed with the Commission on December 26, 2012, and any amendment or report filed for the purpose of updating such description, including Exhibit 4.6 to the Form 10-K. |
All documents filed by the Company pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, subsequent to the filing of this registration statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of filing such documents, except as to specific sections of such documents as set forth therein. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement.
Item 8. Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tucson, State of Arizona, on May 14, 2024.
| ACCELERATE DIAGNOSTICS, INC. | ||
| By: | /s/ Jack Phillips | |
| Name: | Jack Phillips | |
| Title: | President and Chief Executive Officer | |
Each person whose signature appears below hereby constitutes and appoints Jack Phillips and David Patience, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with any and all exhibits thereto, and other documents in connection therewith, with the Commission, and hereby grants to such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date |
|
/s/ Jack Phillips Jack Phillips |
President, Chief Executive Officer and Director (Principal Executive Officer) |
May 14, 2024 |
|
/s/ David Patience David Patience |
Chief Financial Officer (Principal Financial and Accounting Officer) |
May 13, 2024 |
|
/s/ Hany Massarany Hany Massarany |
Chairman of the Board of Directors | May 13, 2024 |
|
/s/ Mark Black Mark Black |
Director | May 13, 2024 |
|
/s/ Wayne Burris Wayne Burris |
Director | May 14, 2024 |
|
/s/ Louise Francesconi Louise Francesconi |
Director | May 14, 2024 |
|
/s/ John Patience John Patience |
Director | May 14, 2024 |
|
/s/ Marran Ogilvie Marran Ogilvie |
Director | May 13, 2024 |
|
/s/ Jack Schuler Jack Schuler |
Director | May 14, 2024 |
|
/s/ Jennifer Regan Jennifer Regan |
Director | May 13, 2024 |